Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Journal of Neurovirology|July 23, 2005
Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohortValerio Tozzi, Pietro Balestra, Patrizia Lorenzini, et al.
Journal of the International AIDS Society|November 15, 2014
Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysisMauro Zaccarelli, Massimiliano Fabbiani, Carmela Pinnetti, et al.
International Journal of Antimicrobial Agents|February 16, 2019
Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitorsGaetana Sterrantino, Vanni Borghi, Anna Paola Callegaro, et al.
Antiviral Therapy|April 28, 2006
Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patientsAndrea Antinori, Maria Paola Trotta, Paola Nasta, et al.
The Journal of Infectious Diseases|April 30, 2004
Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohortValerio Tozzi, Mauro Zaccarelli, Pasquale Narciso, et al.
Antiviral Therapy|May 12, 2004
Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAARTAndrea Antinori, Alessandro Cozzi-Lepri, Adriana Ammassari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2004
Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapyMauro Zaccarelli, Carlo Federico Perno, Federica Forbici, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2010
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimensValentina Svicher, Claudia Alteri, Anna Artese, et al.
The Journal of Antimicrobial Chemotherapy|August 8, 2006
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatmentStefano Aquaro, Roberta D'Arrigo, Valentina Svicher, et al.
AIDS Patient Care and Stds|April 22, 2008
Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretroviralsMaria Paola Trotta, Adriana Ammassari, Rita Murri, et al.
Pageof 9